Arena Pharmaceuticals

(

ARNA

) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.4%. By the end of trading, Arena Pharmaceuticals fell 4 cents (-0.7%) to $6 on light volume. Throughout the day, 6.6 million shares of Arena Pharmaceuticals exchanged hands as compared to its average daily volume of 14.2 million shares. The stock ranged in price between $5.88-$6.05 after having opened the day at $5.99 as compared to the previous trading day's close of $6.04. Other company's within the Health Care sector that declined today were:

Delcath Systems

(

DCTH

), down 37%,

Rosetta Genomics

(

ROSG

), down 18.7%,

Vermillion

(

VRML

), down 18.4%, and

Prima Biomed Ltd. ADR

(

PBMD

), down 12.6%.

Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena Pharmaceuticals has a market cap of $1.2 billion and is part of the

drugs

industry. Shares are up 223% year to date as of the close of trading on Thursday. Currently there are four analysts that rate Arena Pharmaceuticals a buy, one analyst rates it a sell, and five rate it a hold.

TheStreet Ratings rates Arena Pharmaceuticals as a

sell

. Among the areas we feel are negative, one of the most important has been an overall disappointing return on equity.

On the positive front,

K-V Pharmaceutical Company

(

KV.A

), up 34.7%,

Complete Genomics

(

GNOM

), up 28.8%,

Medgenics

(

MDGN

), up 25.5%, and

ARCA biopharma

(

ABIO

), up 25.4%, were all gainers within the health care sector with

Cigna

(

CI

) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

null